The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice

Obesity

Volumn 22, Issue 11, 2014, Pages 2301-2311

  Myronovych, Andriy ^a   Salazar Gonzalez, Rosa Maria ^a   Ryan, Karen K ^b   Miles, Lili ^a   Zhang, Wujuan ^a   Jha, Pinky ^a   Wang, Li ^c   Setchell, Kenneth D R ^a   Seeley, Randy J ^b   Kohli, Rohit ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; CELL NUCLEUS RECEPTOR; SMALL HETERODIMER PARTNER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CELL RECEPTOR; NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; GENE EXPRESSION; LIPID DIET; LIPOGENESIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHENOTYPE; SIGNAL TRANSDUCTION; SLEEVE GASTRECTOMY; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; COMPLICATION; GASTRECTOMY; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MOUSE MUTANT; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY;

ANIMALS; DIET, HIGH-FAT; GASTRECTOMY; INFLAMMATION; LIPOGENESIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; WEIGHT GAIN; WEIGHT LOSS;

EID: 84910122590     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20890     Document Type: Article

References (34)

1. Liu Q, Bengmark S, Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis 2010;9:42.
2. Bohinc BN, Diehl AM. Mechanisms of disease progression in NASH: new paradigms. Clin Liver Dis 2012;16:549-565.
3. Pontiroli AE, Benetti A, Folini L, Merlotti C, Frige F. Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. Nutr Hosp 2013;28 Suppl 2:104-108.
4. Mottin CC, Moretto M, Padoin AV, et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005;15:788-793.
5. Myronovych A, Kirby M, Ryan KK, et al. Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner. Obesity (Silver Spring) 2014;22:390-400.
6. Kohli R, Bradley D, Setchell KD, et al. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 2013;98:E708-E712.
7. Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013;21:E660-E668.
8. Fuchs C, Claudel T, Trauner M. Bile acid-mediated control of liver triglycerides. Semin Liver Dis 2013;33:330-342.
9. Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014;509:183-188.
10. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011;1812:893-908.
11. Adorini L, Pruzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discov Today 2012;17:988-997.
12. Calkin AC, Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 2012;13:213-224.
13. Wang L, Lee YK, Bundman D, et al. Redundant pathways for negative feedback regulation of bile acid production. Develop Cell 2002;2:721-731.
14. Zhang Y, Soto J, Park K, et al. Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol Cell Biol 2010;30:1341-1356.
15. Hagio M, Matsumoto M, Fukushima M, Hara H, Ishizuka S. Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS. J Lipid Res 2009;50:173-180.
16. Huang J, Iqbal J, Saha PK, et al. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 2007;46:147-157.
17. Wang L, Liu J, Saha P, et al. The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes. Cell Metab 2005;2:227-238.
18. Bechmann LP, Kocabayoglu P, Sowa JP, et al. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology 2013;57:1394-1406.
19. Boulias K, Katrakili N, Bamberg K, et al. Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP. EMBO J 2005;24:2624-2633.
20. Goodwin B, Jones SA, Price RR, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000;6:517-526.
21. Watanabe M, Houten SM, Wang L, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Investig 2004;113:1408-1418.
22. Wang L, Han Y, Kim CS, Lee YK, Moore DD. Resistance of SHP-null mice to bile acid-induced liver damage. J Biol Chem 2003;278:44475-44481.
23. Yang CS, Yuk JM, Kim JJ, et al. Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2. PloS One 2013;8:e63435.
24. Yuk JM, Shin DM, Lee HM, et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat Immunol 2011;12:742-751.
25. Schiff ER, Small NC, Dietschy JM. Characterization of the kinetics of the passive and active transport mechanisms for bile acid absorption in the small intestine and colon of the rat. J Clin Investig 1972;51:1351-1362.
26. Mottino AD, Hoffman T, Dawson PA, et al. Increased expression of ileal apical sodium-dependent bile acid transporter in postpartum rats. Am J Physiol Gastrointest Liver Physiol 2002;282:G41-G50.
27. Kohli R, Kirby M, Setchell KD, et al. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol 2010;299:G652-660.
28. Kohli R, Setchell KD, Kirby M, et al. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology 2013;154:2341-2351.
29. Habegger KM, Al-Massadi O, Heppner KM, et al. Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut 2014;63:1238-1246.
30. Perkins WJ, Hale ER, Fernandez AZ, Dawson P, Weinberg RB. Mo2046 Differential effects of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass on dietary fatty acid absorption, bile acid absorption, and post-prandial gut hormone secretion. Gastroenterology 2014;146:S-726-S-727.
31. Kang K, Schmahl J, Lee JM, et al. Mouse ghrelin-O-acyltransferase (GOAT) plays a critical role in bile acid reabsorption. FASEB J 2012;26:259-271.
32. Vos TA, Ros JE, Havinga R, et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 1999;29:1833-1839.
33. Kir S, Kliewer SA, Mangelsdorf DJ. Roles of FGF19 in liver metabolism. Cold Spring Harbor Symp Quant Biol 2011;76:139-144.
34. Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005;2:217-225.